EUVIMEDEUVIMED entdecken
Crossref

All-Small-Molecule Supramolecular Hydrogel Combining Self-Delivery and ROS-Responsive Release for Inhibiting Tumor Growth and Postoperative Recurrence

Linjun Zou, Yong Hou, Xueqiang Nie, Shengchen Wang, Sichao Tian, Zhaocui Sun iD, Zhonghao Sun, Xudong Xu, Guang Li, Guoxu Ma iD, Haitao Liu

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.4c20852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Linjun Zou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education; State Key Laboratory of Bioactive …. Hauptthemen laut MEDLINE: Hydrogels, Reactive Oxygen Species, Antineoplastic Agents, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: CAMS Innovation Fund for Medical Sciences (CIFMS), Yunnan Key Laboratory of Southern Medicine Utilization, Natural Science Foundation of Henan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Supramolecular hydrogels show unprecedented advantages and have attracted widespread attention in biomedical sciences. However, it is challenging for bioactive star molecules, such as celastrol, to meet ideal formation conditions. Here, we report a dynamic covalent method to construct a dihydrol-type celastrol-phenylenediboronic acid-guanosine (DHcelPBG) supramolecular hydrogel. The DHcelPBG hydrogel can effectively accelerate 4T1 cell apoptosis by modulating the PI3K/Akt signaling pathway. Especially, the DHcelPBG hydrogel can serve as a self-delivery platform for reactive oxygen species (ROS)-facilitated self-release. An excessive ROS-containing tumor microenvironment can promote the obtained DHcelPBG hydrogel to kill more 4T1 tumor cells. Meanwhile, the hydrogel also exhibits distinguished degradability and biocompatibility. Subsequently, the orthotopic 4T1 tumor model results further demonstrate that the DHcelPBG hydrogel remarkably inhibits tumor growth and does not damage healthy tissue. In the postoperative recurrence 4T1 tumor model, the DHcelPBG hydrogel also effectively prevents postoperative tumor recurrence and lung metastasis without causing adverse side effects, resulting in an extended lifetime. The DHcelPBG hydrogel also exhibits distinguished degradability and biocompatibility. The DHcelPBG hydrogel integrates ROS-responsiveness, localized self-delivery, and antitumor activity into one system for breast cancer treatment with fewer side effects, showing great potential for clinical transformation in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsReactive Oxygen SpeciesAntineoplastic AgentsNeoplasm Recurrence, LocalAnimalsMiceCell Line, TumorFemaleMice, Inbred BALB CPentacyclic TriterpenesApoptosisHumansCell Proliferation

Stichwörter der Autor:innen

ROS-responsivebreast cancercelastroldihydrocelastrolsupramolecular dynamic hydrogel

Substanzen

HydrogelsReactive Oxygen SpeciesAntineoplastic AgentsPentacyclic Triterpenescelastrol

Autor:innen und Institutionen

  • Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education; State Key Laboratory of Bioactive Substance and Function of Natural Medicines; Institute of Medicinal Pl…
  • Department of Neurosurgery, Shenzhen Key Laboratory of Neurosurgery, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen 518035, China.
  • Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Jinghong 666100, China.

ORCID-Profile: Zhaocui Sun, Guoxu Ma

Förderung

  • CAMS Innovation Fund for Medical Sciences (CIFMS)
  • Yunnan Key Laboratory of Southern Medicine Utilization
  • Natural Science Foundation of Henan

Zitieren

APA

Zou, L., Hou, Y., Nie, X., Wang, S., Tian, S., Sun, Z., Sun, Z., Xu, X., Li, G., Ma, G., & Liu, H. (2025). All-Small-Molecule Supramolecular Hydrogel Combining Self-Delivery and ROS-Responsive Release for Inhibiting Tumor Growth and Postoperative Recurrence. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c20852

Vancouver

Zou L, Hou Y, Nie X, Wang S, Tian S, Sun Z, et al. All-Small-Molecule Supramolecular Hydrogel Combining Self-Delivery and ROS-Responsive Release for Inhibiting Tumor Growth and Postoperative Recurrence. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c20852

BibTeX
@article{Zou2025,
  author = {Zou, Linjun and Hou, Yong and Nie, Xueqiang and Wang, Shengchen and Tian, Sichao and Sun, Zhaocui and Sun, Zhonghao and Xu, Xudong and Li, Guang and Ma, Guoxu and Liu, Haitao},
  title = {All-Small-Molecule Supramolecular Hydrogel Combining Self-Delivery and ROS-Responsive Release for Inhibiting Tumor Growth and Postoperative Recurrence},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.4c20852}
}
Kostenlos starten →